CDK8 and malignant colon neoplasm: The latter finding parallels the preferential effect of CDK8/19i against hepatic metastases versus primary tumors in colon cancer (12) and the results with the murine E0771 TNBC model, where Cdk8 knockdown decreased the metastatic burden in the lungs but not the primary tumor growth (22).